Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss
The post Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast appeared first on Reuters News Agency.
Reuters was two-and-a-half minutes ahead of rivals on Eli Lilly’s unscheduled trading update, which showed fourth-quarter sales of its weight-loss drug Zepbound would miss Wall Street estimates. The drugmaker’s shares slumped 8% on the news.
The post Lilly shares on track for worst day since 2021 after downbeat Zepbound sales forecast appeared first on Reuters News Agency.
Reuters News Agency Read More
Discover more from GMDegens.io
Subscribe to get the latest posts sent to your email.


